Login To Trade  |  About IIFL
  • NIFTY  8567.95  51.05 0.6%
  • SENSEX 28223.08  151.15 0.54%

Dr. Reddy launches Sildenafil tablets

India Infoline News Service | Mumbai | November 19, 2012 09:51 IST

The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.

Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.


The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.


Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.

BSE 4,194.95 28.80 (0.69%)
NSE 4,191.80 30.05 (0.72%)

***Note: This is a NSE Chart


Turn your smartphone into a powerful mobile trading platform - Know more!!!

Read more on: Dr.  Reddy,Sildenafil  tablets 
article
113110705590
Dr. Reddy launches Sildenafil tablets
Dr. Reddy launches Sildenafil tablets
The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.
http://www.indiainfoline.com/article/news-top-story/dr-reddy-launches-sildenafil-tablets-113110705590_1.html
November 19, 2012 09:51 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Dr. Reddy,Sildenafil tablets
Others
$rawVideoFileUrl$
$videoPlayerUrl$
Recent Reports

Revival some time away

India Infoline Research Team / 10:30, Jul 13, 2015

Tourism Finance Corp (TFCIL), a niche financier of tourism related projects and activities, has witnessed a sharp moderation in loan growth from 32% in FY12 to just 1% in FY14

News